
Sequencing and COVID-19
A growing number of methods and products are being developed and shared by the scientific community around the world for use in COVID-19-related work. A selection of preprints and protocols is shown below. These include methods for sequencing of SARS-CoV-2 and metatranscriptome analysis of COVID-19 samples, with applications in areas including epidemiology, metagenomic analysis and diagnostics.
Please note that preprints, protocols, and early access publications have not completed a peer-review process.
Nanopore sequencing
![]() |
NEBNext® ARTIC SARS-CoV-2 Companion Kit (Oxford Nanopore Technologies®) |
![]() |
nCoV-2019 sequencing protocol v3 (LoCost) This new version of the ARTIC protocol updates the RT and ligation reagents used, reduces reaction volumes and enables increased multiplexing. This updated method is also described in a bioRxiv preprint Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore.
|
![]() |
nCoV-2019 sequencing protocol v2 ARTIC amplicon sequencing protocol for MinION for nCoV-2019, incorporating one-pot native barcoding.
|
![]() |
PCR tiling of SARS-CoV-2 virus with Native Barcoding Expansion 96 (EXP-NBD196) This method, based on the ARTIC Network protocol by Josh Quick (see above), generates 400bp tiled amplicons and includes updated cDNA synthesis and ligation steps. The method enables additional barcoding and is compatible with Oxford Nanopore Technologies sequencing on MinION or GridION.
|
![]() |
PCR tiling of SARS-CoV-2 virus This updated version of this protocol, based on the ARTIC Network protocol by Josh Quick, generates 400bp tiled amplicons, followed by Oxford Nanopore Technologies sequencing. This version includes updated cDNA synthesis and ligation steps.
|
![]() |
nCoV-2019 environmental sample sequencing protocol
|
![]() |
LamPORE: rapid, accurate and highly scalable molecular screening for SARS-CoV-2 infection, based on nanopore sequencing James, P. et al. Oxford Nanopore Technologies This fast, scalable method has testing and screening applications, employing LAMP-based amplification followed by library construction and nanopore sequencing.
|
![]() |
Long reads nanopore sequencing to recover SARS-CoV-2 whole genome v.3 This protocol builds long (~2kb) amplicon libraries of SARS-CoV-2 genomes, suitable for nanopore sequencing.
|
![]() |
Rapid detection of SARS-CoV-2 and other respiratory viruses by using LAMP method with Nanopore Flongle workflow This method combines LAMP with the Oxford Nanopore Flongle workflow, to detect SARS-CoV-2 and other respiratory viruses.
|
Illumina sequencing
![]() |
NEBNext® ARTIC SARS-CoV-2 FS Library Prep Kit (Illumina®) NEBNext® ARTIC SARS-CoV-2 Library Prep Kit (Illumina®) These new kits include balanced ARTIC primer pools plus reagents optimized for RT-PCR from SARS-CoV-2 gRNA and downstream library preparation, including enzymatic cDNA fragmentation. The E7658 kit generates library inserts in the 150 bp range, compatible with 2 x 75 sequencing on Illumina instruments, while the E7650 kit (link to E7650 PDP) libraries are ~400 bp, compatible with 2 x 250 sequencing. RT reaction conditions are the same for all input amounts, and a novel DNA polymerase eliminates the need to normalize amplicon concentrations prior to library preparation. The methods increase uniformity of genome coverage, across a wide copy number range, and are based on the original work of the ARTIC Network. |
![]() |
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol V.5 Using the ARTIC SARS-CoV-2 primers, this protocol generates libraries of 400bp tiled amplicons, followed by sample pooling and sequencing on the Illumina NovaSeq.
|
![]() |
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - high throughput 384 format V.2 For higher density of sample processing, this adaptation of the COVID-19 ARTIC v3 protocol is compatible with 384 samples.
|
![]() |
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - short amplicons (275bp) This protocol describes production of 275nt amplicons, followed by library preparation and sample pooling. Any Illumina instrument with a 300 cycle (or greater) kit can then be used for sequencing.
|
![]() |
COVID-19 ARTIC v3 Illumina library construction and sequencing protocol - tailed method This adaptation of the COVID-19 ARTIC v3 protocol makes libraries directly from the 400bp tiled amplicons, using a second PCR step and without conventional library construction.
|
![]() |
SARS-CoV-2 Enrichment Sequencing by Spiked Primer MSSPE method V.4 Incorporating a spiked primer enrichment step, this protocol generates libraries suitable for sequencing on the Illumna iSeq100.
|
![]() |
Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions This preprint describes a large-scale shotgun metatranscriptomic profiling platform for nasopharyngeal swabs, with Illumina sequencing, and use of Colorimetric LAMP to detect SARS-CoV-2 infection.
|
![]() |
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States This publication includes RNA library preparation from passaged virus sequencing on the Illumina MiniSeq.
|
![]() |
Early Spread of SARS-Cov-2 in the Icelandic Population Using the ARTIC tiled primer method, the authors generated libraries which were pooled and sequenced on the Illumina MiSeq.
|
![]() |
Introductions and early spread of SARS-CoV-2 in France The authors sequenced samples collected in France between January and March, 2020, including samples with low viral loads (<10,000 viral copies/ul of extracted RNA).
|
![]() |
LAMP-Seq: Population-Scale COVID-19 Diagnostics Using Combinatorial Barcoding This method proposes use of barcoded RT-LAMP followed by large-scale pooling, PCR amplification with additional barcoding and deep sequencing on the Illumina platform.
|
Product Citation Tool
View citations that utilize NEB products using the Product Citation Tool. Refine your search by updating search field and then selecting a filter type. For your convenience, COVID-19 has been selected as a filter on this page.
"GMP-grade" is a branding term NEB uses to describe reagents manufactured at NEB’s Rowley facility. The Rowley facility was designed to manufacture reagents under more
rigorous infrastructure and process controls to achieve more stringent product specifications and customer requirements. Reagents manufactured at NEB’s Rowley facility are
manufactured in compliance with ISO 9001 and ISO 13485 quality management system standards. However, at this time, NEB does not manufacture or sell products known as
Active Pharmaceutical Ingredients (APIs), nor does NEB manufacture its products in compliance with all of the Current Good Manufacturing Practice regulations.
One or more of these products are covered by patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc. For more information, please email us at [email protected]. The use of these products may require you to obtain additional third party intellectual property rights for certain applications.
Welcome to the COVID-19 researcher spotlight
Hear from scientists around the world as they discuss publications related to COVID-19, new protocols and techniques for detection and characterization, as well as how the scientific community is coming together to address this pandemic...all in 19 minutes or less!
In this episode, NEB senior scientist Bijoyita Roy explains the landscape and timeline of COVID-19 vaccine development, focusing on the mRNA vaccine platform and how NEB is helping improve mRNA vaccine development and production.
Listen nowPast researcher spotlight topics
Catch up on previous discussions related to COVID-19 research in these podcasts and videos:
- COVID-19 Researcher Spotlight: Interview with Chan Zuckerberg Biohub Scientists
- COVID-19 Researcher Spotlight: Interview with Joshua Quick
- COVID-19 Researcher Spotlight: Interview with Chris Mason
- Lessons from Lab and Life Podcast – Interview with Naama Geva-Zatorsky: Applying LAMP to unpurified swab and saliva samples
- COVID-19 Researcher Spotlight: Interview with Nathan Tanner
- COVID-19 Researcher Spotlight: Interview with Greg Patton
- Lessons from Lab and Life Podcast – Interview with the founders of STOPCovid: Feng Zhang, Omar Abudayyeh and Jonathan Gootenberg
- Lessons from Lab and Life Podcast – Interview with Brian Rabe: Applying RT-LAMP to develop a fast SARS-CoV-2 diagnostic assay
- NEB TV Ep. 23 – Colorimetric LAMP in point-of-care diagnostics
Doing COVID-19 related research?
Let us know what you are working on, so we can keep you informed on new COVID-19 related products and publications available from NEB.
Stay InformedInterested in larger quantities?
Requests to obtain any of these products in
larger quantities in connection with the COVID-19
crisis should be forwarded to [email protected].
For more general inquiries or questions, please
feel free to contact us at [email protected].